The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

Abstract This study aimed to prove that the FibroScan-aspartate aminotransferase (FAST) scores can be used to stratify disease severity in a Japanese cohort with fatty liver diseases [metabolic dysfunction-associated fatty liver disease (MAFLD) and nonalcoholic fatty liver disease (NAFLD)]. All the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hideki Fujii, Shinya Fukumoto, Masaru Enomoto, Sawako Uchida-Kobayashi, Tatsuo Kimura, Akihiro Tamori, Yuji Nadatani, Shingo Takashima, Naoki Nishimoto, Norifumi Kawada
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/e1ed949c073c40da8db5b7808859e73e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares